Loading...
Images of John Pottage
(0 from 0 )News
Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients
www.bloomberg.com
[Bloomberg] - “Viking-3 was designed to address a significant medical need in one of the most difficult populations to treat,” John Pottage, chief scientific and medical officer of ViiV, said in the statement. “We are encouraged by these results.” In the first of
Google News: Peters and Peters | JIBFL_2012_Laming Quereee 2.pdf
[Linex Legal (press release) (registration)] - IntroductIon nFollowing the Financial Services Authority's (FSA) recent disappointment in the Upper Tribunal (the Tribunal) in the FSA v John Pottage appeal, the regulator has enjoyed what it must consider to be a welcome success in resisting
sorted by relevance / date